Forbes Medi-Tech Inc.
OTC Bulletin Board : FMTI

January 14, 2010 09:00 ET

Forbes Medi-Tech Appeals NASDAQ Listing Suspension

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Jan. 14, 2010) - Forbes Medi-Tech Inc. (NASDAQ:FMTI) ("Forbes" or "Company") announced today that it has provided The Nasdaq with a notice of appeal of the Nasdaq Staff Deficiency determination to a Hearings Panel ("Panel").

The Nasdaq Staff Deficiency determination indicated that the Company does not meet The Nasdaq Capital Market ("NASDAQ") initial listing standard as set forth in Listing Rule 5505.

The Company will be preparing a plan to regain compliance with the NASDAQ initial listing standard and will be submitting the plan to the Panel.

If the Company's appeal is not successful, the Company intends to make application to have the Company's securities eligible to trade on the OTC Bulletin Board.

About Forbes Medi-Tech

Forbes Medi-Tech Inc. is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reducol(TM) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower "LDL" cholesterol levels safely and naturally. Building upon established partnerships with leading retailers and manufacturers across the globe, Forbes helps its customers to develop private label and branded products. For more information about Forbes Medi-Tech, please visit www.forbesmedi.com.

Reducol(TM) is a trademark of Forbes Medi-Tech Inc.

Forward looking Statements and Risks

This News Release contains forward-looking statements and forward-looking information, within the meaning of applicable securities laws (collectively, "forward-looking statements"), regarding the Company's listing on NASDAQ. Forward-looking statements can be identified by forward-looking terminology such as "if", "will", "can be", "may", "intends", and similar expressions or variations thereon. Forward-looking statements are inherently uncertain, and actual results may differ materially from the forward-looking statements due to a variety of risks, uncertainties and other factors, including, without limitation, uncertainty whether the appeal will be successful, failing which, the Company's securities will be delisted by Nasdaq; the risk that delisting of the Company's securities may have a material adverse effect on the Company's share liquidity and trading price and on the Company's ability to obtain financing and continue its business. For a further discussion of these and other known risks and uncertainties affecting the Company and its business, please see our latest Annual Information Form / Form 20-F, and other documents filed by us with Canadian and U.S. securities regulatory authorities at www.sedar.com and www.sec.gov. Forward-looking statements are based on the beliefs, assumptions, and expectations of the Company's management at the time they are made, and the Company does not assume any obligation, except as required by law, to update its forward-looking statements if those beliefs, assumptions, or expectations or other circumstances should change.

Contact Information